🔎 Trials Near Me

홈 › 유방암 › 인디애나

인디애나의 유방암 임상 시험

유방암 관련 연구 35개가 인디애나 내 여러 지역에서 참여자를 모집하고 있습니다.

인디애나의 도시

공식 연구 텍스트(영어)

Beamion BCGC-1: A Study to Find a Suitable Dose of Zongertinib Used Alone and in Combination With Other Treatments to Test Whether it Helps People With Different Types of HER2+ Cancer That Has Spread

  • Community Health Network, Indianapolis
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 9. 30. 업데이트됨 · NCT06324357

Phase IIIb Study of Ribociclib + ET in Early Breast Cancer

  • Investigative Clinical R of Indiana, Indianapolis
피험자 모집 중3상
18세 ~ 100세 · 모든 성별 · 2026. 9. 29. 업데이트됨 · NCT05827081

A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)

  • Fort Wayne Medical Oncology and Hematology ( Site 0084), Fort Wayne
  • Franciscan Health ( Site 0077), Indianapolis
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 25. 업데이트됨 · NCT06966700

Signatera-Guided CDK4/6 Inhibitor Therapy in Breast Cancer

  • Northwest Cancer Center, Dyer
  • Indiana University, Indianapolis
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 9. 23. 업데이트됨 · NCT07214532

A Study of Imlunestrant (LY3484356) in Premenopausal Women With Estrogen Receptor-Positive (ER+) Human Epidermal Growth Factor Receptor 2 Negative (HER2-) Early Breast Cancer

  • Indiana University Melvin and Bren Simon Cancer Center, Indianapolis
피험자 모집 중2상
18세 이상 · 여성 · 2026. 9. 22. 업데이트됨 · NCT07287098

A Study of LY4337713 in Participants With FAP-Positive Solid Tumors

  • Indiana University (IU) School of Medicine, Indianapolis
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07213791

A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)

  • Indiana University Health University Hospital, Indianapolis
  • Deaconess GI Specialty Center, Newburgh
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 22. 업데이트됨 · NCT07174336

A Study of Elacestrant Versus Standard Endocrine Therapy in Women and Men With ER+,HER2-, Early Breast Cancer With High Risk of Recurrence

  • Northwest Cancer Centers, PC, Dyer
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 15. 업데이트됨 · NCT06492616

Open-Label Study of BBO-10203 in Subjects With Advanced Solid Tumors

  • Indiana University Simon Comprehensive Cancer Center, Indianapolis
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 9. 9. 업데이트됨 · NCT06625775

Toci +/- SOC Chemo for Metastatic Triple Negative and ER-positive, HER2-negative Breast Cancers

  • IU Health Joe and Shelly Schwarz Cancer Center, Carmel
  • Indiana University Melvin and Bren Simon Comprehensive Cancer Center, Indianapolis
  • Sidney and Lois Eskenazi Hospital, Indianapolis
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT05846789

Phase 3 Study of RLY-2608 + Fulvestrant vs Capivasertib + Fulvestrant as Treatment for Locally Advanced or Metastatic PIK3CA-mutant HR+/HER2- Breast Cancer

  • Community Health Network, Inc, Indianapolis
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT06982521

Evaluating Minimal Residual Disease (MRD) Through Longitudinal Circulating Tumor DNA (ctDNA) Profiling in Breast Malignancies

  • Goshen Center for Cancer Care, Goshen
피험자 모집 중관찰 연구
18세 ~ 99세 · 모든 성별 · 2026. 9. 3. 업데이트됨 · NCT07211178

Study of the Bria-IMT Regimen and CPI vs Physicians' Choice in Advanced Metastatic Breast Cancer.

  • Northwest Cancer Center, Dyer
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT06072612

Collecting Blood Samples From Patients With and Without Cancer to Evaluate Tests for Early Cancer Detection

  • Reid Health, Richmond
피험자 모집 중관찰 연구건강한 지원자 환영
40세 ~ 75세 · 모든 성별 · 2026. 9. 2. 업데이트됨 · NCT05334069

Evaluating the Addition of Adjuvant Chemotherapy to Ovarian Function Suppression Plus Endocrine Therapy in Premenopausal Patients With pN0-1, ER-Positive/HER2-Negative Breast Cancer and an Oncotype Recurrence Score Less Than or Equal to 25

  • IU Health West Hospital, Avon
  • IU Health North Hospital, Carmel
  • UChicago Medicine Northwest Indiana, Crown Point
  • 외 12개
피험자 모집 중3상
18세 ~ 60세 · 여성 · 2026. 9. 2. 업데이트됨 · NCT05879926

A Study of Dato-DXd in Inoperable or Metastatic Hormone Receptor-positive, HER2 IHC 0 Breast Cancer

  • Research Site, Fort Wayne
피험자 모집 중3상
18세 이상 · 모든 성별 · 2026. 8. 28. 업데이트됨 · NCT07205822

HER2 Vaccine for Locally Advanced Breast Cancer

  • Indiana University Melvin & Bren Simon Comprehensive Cancer Center, Indianapolis
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 27. 업데이트됨 · NCT06949410

HER-2 B Cell Peptide Vaccine

  • Indiana University Melvin & Bren Simon Comprehensive Cancer Center, Indianpolis
피험자 모집 중1상
18세 이상 · 모든 성별 · 2026. 8. 27. 업데이트됨 · NCT06414733

Low Dose Aspirin for the Prevention of Postpartum Related Breast Cancer

  • Indiana University Simon Comprehensive Cancer Center, Indianapolis
피험자 모집 중2상건강한 지원자 환영
18세 ~ 45세 · 여성 · 2026. 8. 20. 업데이트됨 · NCT05557877

E-Mindfulness Approaches for Living After Breast Cancer

  • Goshen Center for Cancer Care, Goshen
  • Baptist Health Floyd, New Albany
  • Memorial Hospital of South Bend, South Bend
피험자 모집 중3상
18세 ~ 50세 · 모든 성별 · 2026. 8. 4. 업데이트됨 · NCT06748222

Integrated Cancer Repository for Cancer Research

  • Parkview Research Center, Fort Wayne
피험자 모집 중관찰 연구건강한 지원자 환영
19세 ~ 110세 · 모든 성별 · 2026. 6. 29. 업데이트됨 · NCT02012699

Exercise in Metastatic Breast Cancer: EMBody

  • Indiana University Melvin & Bren Simon Cancer Center, Indianapolis
피험자 모집 중
18세 이상 · 모든 성별 · 2026. 4. 27. 업데이트됨 · NCT05468034

De-Escalation of Breast Radiation Trial for Hormone Sensitive, HER-2 Negative, Oncotype Recurrence Score Less Than or Equal to 18 Breast Cancer (DEBRA)

  • Northwest Cancer Center - Main Campus, Crown Point
  • UChicago Medicine Northwest Indiana, Crown Point
  • Northwest Oncology LLC, Dyer
  • 외 9개
피험자 모집 중3상
50세 ~ 70세 · 모든 성별 · 2026. 4. 23. 업데이트됨 · NCT04852887

Avelumab or Hydroxychloroquine With or Without Palbociclib to Eliminate Dormant Breast Cancer

  • Indiana University, Indianapolis
피험자 모집 중2상
18세 이상 · 모든 성별 · 2026. 4. 9. 업데이트됨 · NCT04841148

Open-Label Study to Evaluate the Safety, Tolerability, PK, and Efficacy of INX-315 in Patients With Advanced Cancer

  • Fort Wayne Medical Oncology and Hematology, Fort Wayne
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 4. 1. 업데이트됨 · NCT05735080

Assessing Benefits and Harms of Cannabis/Cannabinoid Use Among Cancer Patients Treated in Community Oncology Clinics

  • Woodland Cancer Care Center, Michigan City
  • Reid Health, Richmond
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 3. 17. 업데이트됨 · NCT06418204

A Phase 1/2 Clinical Trial to Assess the Safety, Tolerability, Pharmacokinetics and Preliminary Efficacy of HMBD-501 in Patients With HER3-Expressing Solid Tumors

  • Research Site, Indianapolis
피험자 모집 중1/2상
18세 이상 · 모든 성별 · 2026. 3. 2. 업데이트됨 · NCT06956690

NearWave Optical Molecular Monitoring

  • Indiana University Simon Comprehensive Cancer Center, Indianapolis
피험자 모집 중
18세 이상 · 여성 · 2026. 2. 17. 업데이트됨 · NCT06744465

cfDNA Assay Prospective Observational Validation for Early Cancer Detection and Minimal Residual Disease

  • Baptist Floyd, New Albany
피험자 모집 중관찰 연구건강한 지원자 환영
40세 이상 · 모든 성별 · 2026. 1. 20. 업데이트됨 · NCT05366881

EXActDNA-003 / NSABP B-64: Study of Molecular Residual Disease Detection in Breast Cancer (MRD)

  • Deaconess Chancellor Center for Oncology, Newburgh
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2026. 1. 20. 업데이트됨 · NCT06401421

S1501 Dual Observational and Randomized Cohort Study of Patients With Metastatic HER-2+ Breast Cancer at Risk of Cardiac Toxicity

  • Franciscan Health Indianapolis, Indianapolis
  • Franciscan Saint Elizabeth Health - Lafayette East, Lafayette
  • Franciscan Health Mooresville, Mooresville
피험자 모집 중3상
18세 이상 · 모든 성별 · 2025. 10. 8. 업데이트됨 · NCT03418961

MammaPrint, BluePrint, and Full-genome Data Linked With Clinical Data to Evaluate New Gene EXpression Profiles

  • Parkview Health, Fort Wayne
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2025. 8. 20. 업데이트됨 · NCT03053193

A Phase 2 Study of PCS6422 With Capecitabine in Patients With Advanced or Metastatic Breast Cancer

  • Northwest Cancer Center, Dyer
피험자 모집 중2상
18세 이상 · 모든 성별 · 2025. 6. 19. 업데이트됨 · NCT06568692

BostonGene and Exigent Genomic INsight Study

  • Fort Wayne Medical Oncology and Hematology, Fort Wayne
피험자 모집 중관찰 연구
18세 이상 · 모든 성별 · 2025. 2. 17. 업데이트됨 · NCT06272864

ClinicalTrials.gov 출처, 2026. 10. 1. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.